US Stock Market Move | Alamar Biosciences (ALMR.US) debuts on the US stock market, opening with a gain of over 34%.

On Friday, Alamar Biosciences (ALMR.US) debuted on the US stock market, opening up more than 34% at $22.91. The IPO price was $17. Alamar Biosciences is a biotechnology company based in California, USA, focusing on the development and application of precision proteomics technology. The company's core product is based on its proprietary NULISA platform, which can detect trace protein biomarkers in blood with high sensitivity, helping researchers to detect diseases earlier, advance drug development, and promote the growth of precision medicine. Its technology is mainly used in research on neurodegenerative diseases such as Alzheimer's and Parkinson's.